BEIJING--(BUSINESS WIRE)--Pharmaron has signed an agreement to provide Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) with nucleoside phosphoramidites at quantities up to 100 kg. Nucleoside phosphoramidites are fundamental building blocks in the production of antisense therapeutics. Isis is the world’s leader in antisense therapeutics with a pipeline of 24 drugs in development.
